FDA cites Lifted Naturals' Mood Boosting Probiotic for website claims that make it an unapproved drug.
What happened
FDA reviewed the website www.liftednaturals.com in December 2020 and determined that Lifted Naturals takes orders there for Mood Boosting Probiotic. The website claimed the product's prebiotic was proven to help anxiety, that the probiotic was designed to help mood and anxiety, and that probiotics could be a first line of defense and prevention for mental health issues. FDA concluded the product is intended to treat or prevent disease and is an unapproved new drug (not generally recognized as safe and effective for its claimed uses and not FDA-approved).
What FDA found
Website claims show the probiotic is intended to cure, mitigate, treat, or prevent disease, so FDA treats it as a drug.
section 201(g)(1)(B) of the Federal Food, Drug, and Cosmetic Act [21 U.S.C. § 321(g)(1)(B)]The product is a new drug (a product not generally recognized as safe and effective for its claimed uses) and was introduced into interstate commerce without FDA approval.
section 201(p) [21 U.S.C. § 321(p)]; sections 301(d) and 505(a) [21 U.S.C. §§ 331(d), 355(a)]The product is misbranded (improperly labeled) because it lacks adequate directions for a layperson to use it safely for its intended uses.
section 502(f)(1) [21 U.S.C. § 352(f)(1)]; 21 C.F.R. § 201.5The misbranded drug was introduced or delivered for introduction into interstate commerce, which violates the law.
section 301(a) [21 U.S.C. § 331(a)]
What FDA wants
FDA asks Lifted Naturals to notify it in writing within 15 working days of receipt of the letter about specific steps taken to address the violations, including an explanation and supporting documents. If the company cannot finish within that time, it must state the reason for delay and when it will finish.
Who should pay attention
- probiotic and supplement brands making mood or anxiety claims
- online sellers of supplements with disease claims
- regulatory and marketing staff who review website copy
This is a summary. Read the original letter on fda.gov.